China News Service, June 18, according to the Kyodo News Agency, the Japanese governor of Osaka Prefecture Yoshimura Yoshimura announced on the 17th that the new coronavirus vaccine being developed by Osaka University’s innovative company “AnGes” will be launched on June 30 for human use. Clinical Trials.
According to reports, the clinical trial will first be conducted with 20 to 30 medical staff at Osaka City University Hospital, and plans to expand the trial subject in October. It is reported that after the vaccine strives to obtain national approval, it is expected to be put into practical use in 2021.
Data picture: The picture shows people wearing masks walking through the streets of Tokyo, Japan. China News Agency reporter Lu Shaowei
Yoshimura said: "I think this is the first time the human body is used in the country. The first step will be taken in Osaka." In April, Osaka Prefecture and Osaka City signed a cooperation agreement with the operating corporations of universities and hospitals in the prefecture to promote development. It is said that animal tests that have been passed so far confirm the safety of (vaccine).
It is reported that if the vaccine is confirmed to be safe for humans in the early stage of clinical trials, it is expected to enter the next stage in October. Through clinical trials of hundreds of people, it is investigated whether the vaccine is expected to obtain the effect of preventing infection and severe disease.
Yoshimura pointed out that "200,000 vaccines can be made within the year" and also stated that he will strive to obtain national approval from spring to autumn in 2021.